Thomas DiRaimondo
Chief Tech/Sci/R&D Officer at JANUX THERAPEUTICS, INC.
Net worth: 5 M $ as of 30/04/2024
Thomas DiRaimondo active positions
| Companies | Position | Start | End |
|---|---|---|---|
| JANUX THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/05/2018 | - |
Career history of Thomas DiRaimondo
Former positions of Thomas DiRaimondo
| Companies | Position | Start | End |
|---|---|---|---|
Sitari Pharma, Inc.
 Sitari Pharma, Inc. BiotechnologyHealth Technology Sitari Pharma, Inc. provides pharmaceutical research and development services. It engages in multiple disease indications such as celiac disease. The company was founded by Chaitan S. Khosla and Thomas DiRaimondo in 2013 and is headquartered in La Jolla, CA. | Founder | 01/01/2013 | 01/08/2019 |
Training of Thomas DiRaimondo
| Stanford University | Doctorate Degree |
| University of Michigan | Graduate Degree |
Statistics
International
| United States | 5 |
Operational
| Founder | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| JANUX THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Sitari Pharma, Inc.
Sitari Pharma, Inc. BiotechnologyHealth Technology Sitari Pharma, Inc. provides pharmaceutical research and development services. It engages in multiple disease indications such as celiac disease. The company was founded by Chaitan S. Khosla and Thomas DiRaimondo in 2013 and is headquartered in La Jolla, CA. | Health Technology |
- Stock Market
- Insiders
- Thomas DiRaimondo
- Experience
